Santander Q4 Profit Rises, Sees Growth Ahead; Launches EUR 5 Bln Buyback

Banco Santander reported stronger results with Q4 attributable profit of €3.76 billion (+15% year-over-year) and FY2025 attributable profit of €14.101 billion (+12%), EPS €0.91 (+17.3%) while total FY income was €58.67 billion (+0.5%). Net operating income rose 2.2% to €33.959 billion though net interest income fell 3.3% to €42.348 billion; total underlying income was €62.39 billion (flat in euros, +4% constant euros). The board approved a €5 billion buyback, reiterated a commitment to distribute at least €10 billion via buybacks against 2025–26 earnings and agreed a ~$12.3 billion cash-and-stock acquisition of Webster Financial, guiding mid-single-digit revenue growth for 2026 (ex-Poland/TSB/Webster) and double-digit revenue plus mid-teens profit growth in 2027 post-Webster.

Analysis

Market structure: Santander (SAN) is the clear near-term winner — €5bn buyback + €10bn distribution commitment and a $12.3bn Webster (WBS) deal materially expand scale and US deposit/loan mix, improving revenue diversification. Direct losers: smaller European peers without capital return programmes (e.g., BBVA) and US regionals facing a stronger cross-border competitor; NII down 3.3% signals ongoing margin pressure that M&A and buybacks are intended to offset, not immediately cure.

Risk assessment: Tail risks include US/UK/Spanish regulatory pushback on Webster (possible remedies or divestitures) and integration costs that could erase expected 2027 mid-teens profit uplift; CET1 dilution >30–100 bps is plausible depending on deal funding and goodwill. Time horizons: immediate (days) — positive repricing on buyback; short-term (weeks–months) — regulatory/Investor Day triggers (Investor Day Feb 25); long-term (2027) — realization of Webster synergies and revenue uplift.

Trade implications: Tactical overweight SAN into Investor Day with 2–3% position size, stop 8–10% and target 15–25% in 6–12 months if regulatory feedback is neutral/positive. Complement with a 9–15 month call spread (buy 12–18% OTM, sell 30–40% OTM) to finance upside exposure while buying a 3-month 7–10% OTM put as protection around approval windows. Pair trade: long SAN / short BBVA (equal notional 1–2%) to capture relative capital-return execution.

Contrarian angles: Consensus underweights the regulatory/integration drag and the exclusion of Poland/TSB/Webster from 2026 guidance — a 2026 miss is more likely than street models expect, creating a 10–20% downside scenario priced-in only after regulatory noise. Historical parallels (cross-border bank buys) show multi-year value realization; if Santander underestimates US credit or integration costs, buyback enthusiasm could reverse, tightening bond spreads — watch CET1 moves and 3Q–4Q 2026 earnings as early warning.

Key Decisions for Investors

• Establish a 2–3% long position in SAN ahead of Investor Day (within 2 weeks), set an 8–10% stop-loss, and target a 15–25% gain over 6–12 months contingent on no adverse regulatory news within 60 days.
• Buy a 9–15 month SAN call spread to express upside with defined risk (buy ~12–18% OTM, sell ~30–40% OTM) sized for 1–2% portfolio risk; this captures the 2027 revenue/profit thesis while capping cost.
• Purchase a 3-month SAN put ~7–10% OTM equal to 25–50% of the long-equity position as downside protection around expected regulatory reviews; reduce hedges if CET1 impact disclosed is <30 bps.
• Execute a pair trade: long SAN (1–2% notional) and short BBVA (BBVA) equal notional (1–2%) to play superior capital return and US scale; unwind if SAN's regulatory approval is explicitly conditioned or if BBVA announces matching buybacks.
• Monitor three binary catalysts in next 30–60 days and act: Investor Day (Feb 25) guidance detail, formal regulatory filing/feedback on Webster, and any disclosed CET1 impact >30 bps — if any trigger is negative, cut SAN exposure by at least half within 5 trading days.